about
Cognitive behavioral therapy for substance use disordersPatient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic reviewThe serotonin transporter gene and risk for alcohol dependence: a meta-analytic review.Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain.Changes in sleep disruption in the treatment of co-occurring posttraumatic stress disorder and substance use disordersCue-induced craving in dependence upon prescription opioids and heroin.Changes in distress intolerance and treatment outcome in a partial hospital setting.High Hostility Among Smokers Predicts Slower Recognition of Positive Facial Emotion.Anxiety sensitivity and illicit sedative use among opiate-dependent women and men.Refining the measurement of distress intolerance.Substance abuse treatment entry, retention, and outcome in women: a review of the literatureCombined Pharmacotherapy and Cognitive-Behavioral Therapy for Anxiety Disorders: Medication Effects, Glucocorticoids, and Attenuated Treatment Outcomes.Readability and comprehension of self-report binge eating measuresPredictors of dropout from psychosocial treatment in opioid-dependent outpatients.The Women's Recovery Group Study: a Stage I trial of women-focused group therapy for substance use disorders versus mixed-gender group drug counseling.Balancing fidelity and adaptation in the dissemination of empirically-supported treatments: The promise of transdiagnostic interventions.Empirically supported treatments for panic disorder.The dissemination and implementation of evidence-based psychological treatments. A review of current efforts.A meta-analysis of the magnitude of biased attention in depression.A haphazard reading of McHugh and Barlow (2010).Comprehension of self-report evidence-based measures of anxiety.The dissemination of computer-based psychological treatment: a preliminary analysis of patient and clinician perceptions.Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation.D-cycloserine for the augmentation of an attentional training intervention for trait anxiety.Cortisol, stress, and attentional bias toward threat.Psychometric Analysis of the Perceptions of Computerized Therapy Questionnaire-Patient Version (PCTQ-P).Examining the latent structure of worry and generalized anxiety in a clinical sample.An Examination of the Association of Distress Intolerance and Emotion Regulation with AvoidanceA novel method for assessing distress intolerance: Adaptation of a measure of willingness to payCost-Efficacy of Individual and Combined Treatments for Panic DisorderDirect-to-Consumer Marketing of Evidence-Based Psychological InterventionsElucidating the Relationship between Worry and Physical HealthEvidence-Based Practice of Cognitive-Behavioral TherapyAvoiding Treatment Failures in Panic DisorderBorderline personality disorder symptoms and treatment seeking over the past 12 months: an investigation using the national comorbidity survey-replication (NCS-R)Nonmedical benzodiazepine use in adults with alcohol use disorder: The role of anxiety sensitivity and polysubstance use
P50
Q22251196-4F3FED86-9BD9-42F5-A270-18CDDD5E8738Q27010022-DC3000E5-AC04-484B-84B2-8867DE426350Q33716681-4006A817-C25D-4168-A4DF-F591FC7239DCQ33818740-91EF8CF5-2084-42E8-A84F-21469545ADC1Q33897092-76881F2E-1F8F-4B3C-AE98-3F49B81F4DC8Q34180281-1265D405-DD08-4B01-B96E-466653574501Q34314874-9430B22C-8756-4F86-8E7C-80D8CEFEA8C6Q35644978-E96A1275-5D47-4B56-8FAB-27B6CDD61DFDQ36274929-F3148CFC-A23E-4B58-A26E-B7233F3C58C7Q36355143-189CF38C-3697-4CD0-AC8F-7E41ECE9C885Q36495737-CC785C9B-3533-4F9A-9D31-6D2AFD992419Q36551965-1EEBCC42-A25B-40A1-B50C-1B3EAE69D864Q36745754-162D14D7-D499-4F69-8399-42286AFA806BQ36836038-2133C662-1803-41CA-8D95-C2943E44DD9DQ36920520-B96E8F44-37C8-4A3C-B61D-7887A04DDF5BQ37441586-F3725EB4-6024-44EA-B6AF-8EBAD2444E5AQ37589162-853358D2-332D-4CBE-BBE1-B215EFEF9FB2Q37689131-D5CD3A44-00BA-48D8-8C57-71004D66CB02Q37807012-05EBB6B8-3CC0-4052-A967-352A92DAFA2DQ37816366-1412EDAB-3529-4698-96C4-67E962EAA41CQ37880737-8189F022-B713-4CD5-A13F-699150A53AEEQ39697006-68F54599-3476-4901-B302-343B201279DEQ43024653-0C67156F-42FA-4142-A68C-07760DF666F4Q43126061-EAE4D1CB-E865-4383-BC59-F5895EF10308Q43146614-6E621EF6-BACC-40AB-830D-86AD0FBC351DQ44164020-C1FCF101-A66E-4D37-92B3-239CB71254CDQ47944182-6EA8E7C1-EE7F-4109-9025-85719742E64BQ60491865-2428C97D-104B-4558-9DFD-1CC4B9524BD1Q60491881-7E739DDC-EEEF-42F6-AA3E-EE878887401BQ60491896-39800034-A94B-4BAF-A254-63B84AB01E18Q60629192-51B3C953-9E0B-4542-87F3-8482BFA85317Q60629197-36ECA3A4-5A8A-4465-8585-60679C3D4461Q60629199-2C6A0B36-2175-4CCF-AE02-21DC4FB9F71DQ60629201-63F0FF52-016E-43DA-B68A-D592E1B49844Q86729118-59815B30-C12A-4463-B316-ED68D38904DDQ90360139-FE2D66C7-DE84-4869-980F-F55A0A0A47F1
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-3011-8697
@en
name
R. Kathryn McHugh
@ast
R. Kathryn McHugh
@en
R. Kathryn McHugh
@es
R. Kathryn McHugh
@nl
type
label
R. Kathryn McHugh
@ast
R. Kathryn McHugh
@en
R. Kathryn McHugh
@es
R. Kathryn McHugh
@nl
altLabel
McHugh RK
@en
prefLabel
R. Kathryn McHugh
@ast
R. Kathryn McHugh
@en
R. Kathryn McHugh
@es
R. Kathryn McHugh
@nl
P106
P1153
15832571300
P21
P31
P496
0000-0002-3011-8697